Best Alpha-Lipoic Acid for Antioxidant Support: Ranked & Reviewed for 2026

ALA functions as a cofactor in mitochondrial energy metabolism — specifically within the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes, which are central to ATP production. At supplemental doses, it also operates as a potent antioxidant in its reduced form (dihydrolipoic acid, or DHLA). DHLA is the form that actually donates electrons to regenerate oxidized glutathione, vitamin C, and vitamin E — which is why researchers use the phrase 'antioxidant network' when describing ALA's downstream effects. The R-enantiomer is the form produced naturally in the body and is preferentially taken up by mitochondria. The S-enantiomer, present in synthetic racemic ALA, is absorbed but appears to contribute less to the biologically relevant effects. Oral ALA is rapidly absorbed — peak plasma concentrations occur within 30–60 minutes — but it's also quickly metabolized, which is why some researchers have explored time-released formulations. At doses used in clinical trials (600mg racemic, or roughly 300mg R-ALA equivalent), circulating ALA is detectable for several hours post-ingestion, which aligns with the twice-daily dosing schedules used in many neuropathy studies.

The R-ALA vs. racemic ALA question is the first thing to settle. Racemic ALA (labeled simply as 'Alpha-Lipoic Acid') contains a 50/50 mix of the R and S enantiomers. Your body only makes the R form naturally, and the R-enantiomer is the one that's taken up by mitochondria and has been most clearly linked to antioxidant network activity. The S form isn't harmful — it's just largely a passenger. So if you're buying racemic 600mg ALA, you're getting roughly 300mg of functionally active R-ALA per capsule. Pure R-ALA products deliver 100% active enantiomer, but they typically cost significantly more per milligram of active content. Dose is the second variable. The human clinical trials that underpin most of the meaningful ALA research used 600mg of racemic ALA daily (often split into two 300mg doses), which is equivalent to about 300mg of R-ALA. If you're considering ALA purely as a daily antioxidant for general healthy aging — not for a specific therapeutic purpose — some researchers suggest lower doses (200–300mg racemic) may be adequate. But if your interest is specifically in neuropathy symptom support or glucose metabolism, the 600mg racemic dose is more consistent with the published literature. Absorption timing matters more with ALA than with most supplements. ALA is best absorbed on an empty stomach — food can reduce peak plasma concentrations by up to 30% in some pharmacokinetic studies. If you're taking 600mg as a single daily dose, taking it 30 minutes before your largest meal is a reasonable approach. If you're splitting the dose (300mg twice daily, which some RCTs used), morning and evening fasting windows work well for most people. Finally, consider bottle size relative to your commitment level. If you've never taken ALA before, a 60-capsule bottle (NOW Foods, 2-month supply) lets you assess tolerability before committing to a 6-month supply. If you're confident ALA is part of your long-term stack, Doctor's Best's 180-capsule format is dramatically more economical. Don't buy R-ALA in bulk unless you have excellent cool storage — it degrades faster than racemic ALA and a 6-month supply left in a warm pantry loses potency.